Antioxidant Theranostic Copolymer‐Mediated Reduction in Oxidative Stress Following Traumatic Brain Injury Improves Outcome in a Mouse Model

نویسندگان

چکیده

Abstract Following a traumatic brain injury (TBI), excess reactive oxygen species (ROS) and lipid peroxidation products (LPOx) are generated lead to secondary beyond the primary insult. A major limitation of current treatments is poor target engagement, which has prevented success in clinical trials. Thus, nanoparticle‐based have received recent attention because their ability increase accumulation retention damaged brain. Theranostic neuroprotective copolymers (NPC3) containing thiol functional groups can neutralize ROS LPOx. Immediate administration NPC3 following controlled cortical impact (CCI) mouse model provides therapeutic window reducing levels at 2.08‐20.83 mg/kg males 5.52‐27.62 females. This NPC3‐mediated reduction oxidative stress improves spatial learning memory males, while females show minimal improvement. Notably, prevents bilateral spread necrosis male mice, was not observed female mice likely accounts for sex‐based differences. Overall, these findings suggest differences scavenger nanoparticle treatments, possible upper threshold antioxidant activity that benefit injured since from treatment lesser extent than mice. article protected by copyright. All rights reserved

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Hypothermia improves outcome from traumatic brain injury.

Hypothermia for patients with severe traumatic brain injury (TBI) remains controversial despite a strong biological rationale and reasonable evidence from the literature. The "negative" Clifton study seems to have reduced enthusiasm for hypothermia, however the aim of this review is to analyse the evidence from all randomised controlled trials (RCT) and meta-analyses on this topic to determine ...

متن کامل

Progesterone protects blood-brain barrier function and improves neurological outcome following traumatic brain injury in rats

Inflammatory responses are associated with blood-brain barrier (BBB) dysfunction and neurological deficits following traumatic brain injury (TBI). The aim of the present study was to investigate the effects of progesterone on the expression of the inflammatory mediators prostaglandin E2 (PGE2), cyclooxygenase-2 (COX-2), nuclear factor κB (NF-κB) and tumor necrosis factor-α (TNF-α) in the brain,...

متن کامل

Xenon improves neurological outcome and reduces secondary injury following trauma in an in vivo model of traumatic brain injury

1 Anaesthetics, Pain Medicine and Intensive Care Section, Department of Surgery and Cancer, Imperial College London, United Kingdom. 2 Department of Anaesthesiology, Medical Center of Johannes Gutenberg University, Mainz, Germany. 3 Department of Anaesthesiology, Klinikum Hanau, Hanau, Germany. 4 Mouse Behavioral Outcome Unit, Focus Program Translational Neurosciences (FTN), Johannes Gutenberg ...

متن کامل

Outcome biomarkers following severe traumatic brain injury.

Trauma is the leading cause of death of people from 1 to 44 years of age. Traumatic brain injury is the main determinant for mortality and morbidity caused by trauma. Outcome prediction is one of the major problems related to severe traumatic brain injury because clinical evaluation has an unreliable predictive value and complicates identification of patients with higher risk of developing seco...

متن کامل

Reduction in ischemic brain injury following the administration of pentoxifylline after transient global ischemia/ reperfusion in a rat model

  Background: It is well known that the hippocampus, the CA1 Pyramidal cells in particular, is selectively vulnerable during global cerebral ischemia. Recently, it is observed that pentoxifylline has a neuroprotective effect. This study explored the pharmacological relationship between ischemia-induced cell death of the hippocampus and the efficacy of a vasodilator agent (pentoxifylline) in the...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Advanced therapeutics

سال: 2023

ISSN: ['2366-3987']

DOI: https://doi.org/10.1002/adtp.202300147